Kymanox Launches KymaBridge for Drug Delivery Device Intelligence

Kymanox has launched KymaBridge, an intelligence platform intended to connect pharmaceutical and biotechnology innovators with drug delivery device technologies, according to Manilatimes.

The platform is positioned around helping sponsors identify suitable drug delivery device technology more quickly. It combines verification by Kymanox subject matter experts with data confirmed by suppliers, the publisher reported.

Verified information for device technology searches

KymaBridge brings together supplier-confirmed product and capability information with Kymanox expert verification. According to Manilatimes, the model is designed to support sponsors evaluating drug delivery device technologies.

For medical and pharmaceutical sales professionals working with delivery-device portfolios, the launch centers on a more direct route for presenting supplier products and capabilities to pharma and biotech organizations. The platform gives device suppliers a verified channel to showcase those offerings, Manilatimes reported.

Focus on pharma, biotech and device suppliers

The launch connects three groups involved in drug delivery device selection: pharma sponsors, biotech innovators and device suppliers. Kymanox describes KymaBridge as an intelligence platform for navigating available technology options while relying on verified and supplier-confirmed information.

As reported by Manilatimes, the platform’s stated goal is to speed the process of identifying the right technology. Its supplier channel also gives organizations a structured way to communicate product and capability information to potential sponsors.

What the launch highlights

• KymaBridge is a newly launched intelligence platform from Kymanox.
• It connects pharma and biotech innovators with drug delivery device technologies.
• Kymanox subject matter experts verify information alongside supplier-confirmed data.
• Device suppliers can use a direct, verified channel to showcase products and capabilities.